Table 1.
Individual # | Nucleotide change | Protein change | Data type | Source |
---|---|---|---|---|
1 | c.139C>T | p.Pro47Ser | exome sequencing | XGS Registry |
2 | c.1459C>T | p.Arg487Trp | exome sequencing | GeneDx |
3 | c.1610G>A | p.Gly537Asp | comprehensive NGS panel; microarray | XGS Registry |
4 | c.1642G>A | p.Gly548Ser | WGS/targeted sequencing | DECIPHER (#287553) |
5 | c.1646G>A | p.Arg549His | exome sequencing; SNP array | DECIPHER (#370261) |
6 | c.1819G>A | p.Asp607Asn | exome sequencing | XGS Registry |
7 | c.2374G>C | p.Gly792Arg | exome sequencing; CGH array | XGS Registry, GeneDx |
8 | c.4042T>C | p.Ser1348Pro | exome sequencing | DECIPHER (#277992) |
9 | c.4370A>G | p.Asp1457Gly | exome sequencing | PMID 30858058 |
10a | c.4432C>T | p.Pro1478Ser | exome sequencing | XGS Registry |
Individuals who joined the XGS Registry also contributed clinical data for this study. The source of data for the other individuals is indicated. Other genetic tests that were also administered are noted under the data type. NGS, next-generation sequencing; WGS, whole-genome sequencing; CGH, comparative genomic hybridization.
Suspected de novo mutation.